Assessment of the Prognostic Role of Ki-67 and Its Optimal Cutoff Value in Early Breast Cancer: A Retrospective Analysis
Background: Breast cancer is a heterogenous group of diseases classified into the biological subtypes luminal A, luminal B, HER2-enriched and triple negative. These subtypes have different treatment response patterns and survival rates. Ki-67 is the most commonly used proliferative marker in breast...
Main Authors: | Wael Makar, Shaimaa Lasheen |
---|---|
Format: | Article |
Language: | English |
Published: |
Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine
2020-12-01
|
Series: | Research in Oncology |
Subjects: | |
Online Access: | https://resoncol.journals.ekb.eg/article_105973_a6a27eb70bcfe4f4a60f607bafcc215d.pdf |
Similar Items
-
Ki-67 as a prognostic marker according to breast cancer molecular subtype
by: Nahed A. Soliman, et al.
Published: (2016-12-01) -
Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer
by: Angela Fischer Maranta, et al.
Published: (2020-06-01) -
Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2019-09-01) -
The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up
by: Lombardi A, et al.
Published: (2021-04-01) -
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold
by: Roberta Maltoni, et al.
Published: (2020-09-01)